HSBC Holdings’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $162K | Buy |
30,956
+7,956
| +35% | +$44.6K | ﹤0.01% | 2662 |
|
|
2025
Q4 | $160K | Sell |
23,000
-20,167
| -47% | -$158K | ﹤0.01% | 2730 |
|
|
2025
Q3 | $335K | Sell |
43,167
-4,021
| -9% | -$31.4K | ﹤0.01% | 2287 |
|
|
2025
Q2 | $410K | Sell |
47,188
-137,064
| -74% | -$993K | ﹤0.01% | 2261 |
|
|
2025
Q1 | $1.48M | Sell |
184,252
-162,946
| -47% | -$1.65M | ﹤0.01% | 1585 |
|
|
2024
Q4 | $3.2M | Sell |
347,198
-18,704
| -5% | -$181K | ﹤0.01% | 1295 |
|
|
2024
Q3 | $3.36M | Sell |
365,902
-26,248
| -7% | -$217K | ﹤0.01% | 1252 |
|
|
2024
Q2 | $3.86M | Buy |
392,150
+108,307
| +38% | +$1.32M | ﹤0.01% | 1148 |
|
|
2024
Q1 | $4.29M | Buy |
283,843
+180,894
| +176% | +$3.28M | ﹤0.01% | 1160 |
|
|
2023
Q4 | $2.22M | Sell |
102,949
-32,489
| -24% | -$599K | ﹤0.01% | 1447 |
|
|
2023
Q3 | $2.52M | Buy |
135,438
+23,773
| +21% | +$555K | ﹤0.01% | 1350 |
|
|
2023
Q2 | $2.84M | Sell |
111,665
-14,972
| -12% | -$377K | ﹤0.01% | 1289 |
|
|
2023
Q1 | $3.25M | Buy |
126,637
+7,746
| +7% | +$207K | ﹤0.01% | 1307 |
|
|
2022
Q4 | $2.75M | Sell |
118,891
-14,125
| -11% | -$381K | ﹤0.01% | 1546 |
|
|
2022
Q3 | $3.44M | Sell |
133,016
-30,040
| -18% | -$1.05M | 0.01% | 1333 |
|
|
2022
Q2 | $5.49M | Buy |
163,056
+11,543
| +8% | +$490K | 0.01% | 1161 |
|
|
2022
Q1 | $11M | Sell |
151,513
-47
| -0% | -$3.39K | 0.01% | 847 |
|
|
2021
Q4 | $14.1M | Buy |
151,560
+70,889
| +88% | +$8.47M | 0.01% | 804 |
|
|
2021
Q3 | $10.2M | Buy |
80,671
+7,129
| +10% | +$1.04M | 0.01% | 872 |
|
|
2021
Q2 | $12.3M | Sell |
73,542
-3,581
| -5% | -$580K | 0.01% | 785 |
|
|
2021
Q1 | $14M | Buy |
77,123
+12,313
| +19% | +$2.86M | 0.02% | 701 |
|
|
2020
Q4 | $12.9M | Buy |
64,810
+43,308
| +201% | +$8.81M | 0.02% | 717 |
|
|
2020
Q3 | $4.72M | Buy |
21,502
+5,506
| +34% | +$1.17M | 0.01% | 974 |
|
|
2020
Q2 | $3.05M | Buy |
+15,996
| New | +$2.8M | 0.01% | 1030 |
|
|
2020
Q1 | – | Sell |
-6,724
| Closed | -$565K | – | 3013 |
|
|
2019
Q4 | $565K | Sell |
6,724
-33,703
| -83% | -$2.56M | ﹤0.01% | 2157 |
|
|
2019
Q3 | $2.74M | Buy |
40,427
+35,960
| +805% | +$2.37M | 0.01% | 1454 |
|
|
2019
Q2 | $297K | Buy |
+4,467
| New | +$260K | ﹤0.01% | 2323 |
|
|
2018
Q4 | – | Sell |
-38,473
| Closed | -$3.32M | – | 2713 |
|
|
2018
Q3 | $3.32M | Buy |
+38,473
| New | +$2.74M | 0.01% | 1294 |
|
|
2017
Q2 | – | Sell |
-23,158
| Closed | -$578K | – | 2258 |
|
|
2017
Q1 | $578K | Buy |
+23,158
| New | +$482K | ﹤0.01% | 1561 |
|
Other funds holding TDOC
VPM
VCM
VC
HSBC Holdings's TDOC Position: Q1 2026 in Review
HSBC Holdings increased its Teladoc Health (TDOC) stake by 35% in Q1 2026, buying an estimated $44.6K and bringing the position to 30,956 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.
HSBC Holdings first reported a position in TDOC in Q1 2017 and has held it in 29 quarters since. The position peaked at $14.1M in Q4 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- HSBC Holdings held 30,956 shares of Teladoc Health worth $162K as of Q1 2026.
- HSBC Holdings bought 7,956 Teladoc Health shares in Q1 2026, an estimated $44.6K.
- Teladoc Health made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2662 holding.
- HSBC Holdings first reported a position in Teladoc Health in Q1 2017 and has held it in 29 quarters since.
- HSBC Holdings's Teladoc Health position peaked at $14.1M in Q4 2021.
- 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.